Chronic News and Research

RSS

Opioid medication does not improve physical function in patients with neuropathic pain

Opioids such as morphine, codeine and Tylenol 3 can be effective for treating pain, however, a new University of Alberta study finds that patients with neuropathic pain taking opioids report no improvements in physical functioning compared to those who were not prescribed opioids.

25 Jan 2016

Heat waves increase mortality risk in patients with lung disease

Heat waves are becoming more common in summer and have health-related consequences. In patients with chronic lung disease, the risk of dying increases by up to 43%, according to an original article by Christian Witt and colleagues in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 878-83).

25 Jan 2016

Chronic exposure to environmental toxin may up risk of neurodegenerative illness

A new study published today in the science journal Proceedings of the Royal Society B indicates that chronic exposure to an environmental toxin may increase risk of neurodegenerative illness. Conducted by scientists at the Institute for EthnoMedicine, a non-profit medical research organization, and the University of Miami Brain Endowment Bank, the study provides a foundation for future research in Alzheimer's disease, ALS and Parkinson's disease.

25 Jan 2016

$Parathyroid hormone may mediate antihypertensive fracture risk$

Parathyroid hormone may mediate antihypertensive fracture risk

Parathyroid hormone levels may be elevated by use of some antihypertensive agents but reduced by others, analysis of the Multi-Ethnic Study of Atherosclerosis suggests.

22 Jan 2016

Positive bosutinib response for elderly blast phase CML patient

A case study suggests that the third-generation tyrosine kinase inhibitor bosutinib may be considered as induction therapy for blast phase chronic myeloid leukaemia in older patients.

22 Jan 2016

Cardiovascular considerations crucial for CML TKI patients

A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia.

22 Jan 2016

BCR–ABL transcript type linked to TKI response, outcomes

The type of BCR–ABL transcript could have an impact on tyrosine kinase inhibitor choice in patients with chronic myeloid leukaemia , according to research published in Blood.

22 Jan 2016

Levels of mitochondrial DNA in the blood may predict chronic kidney disease risk

The health of blood cells' energy-producing mitochondria may predict a person's risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

22 Jan 2016

Study finds possibility of targeting Orai3 as novel treatment for obesity-related inflammation

A new study by a team of Rosalind Franklin University researchers headed by Carl White, PhD, assistant professor of physiology and biophysics, has discovered that the degree of chronic inflammation caused by obesity is highly dependent on levels of the signaling molecule, hydrogen sulfide, which alters the activity of a calcium channel, Orai3.

22 Jan 2016

New interprofessional program aims to provide primary care and dental services to older adults

Primary care within a dental practice? It's an interdisciplinary idea that has teeth: Your mouth, noted the U.S. surgeon general in the Oral Health in America report, provides a window into your overall health. Now, a research team led by Maria Dolce, an associate professor in the School of Nursing at Northeastern, will make that idea a reality.

22 Jan 2016

New study identifies DKK3 as a driver of kidney fibrosis

Chronic kidney disease can develop in response to a variety of insults and is characterized by progressive renal fibrosis and atrophy of kidney tubule. Therapeutic options are limited and the disease is often not detected until later stages.

22 Jan 2016

People suffering from chronic stress, anxiety may be at increased risk for depression and dementia

A scientific review paper warns that people need to find ways to reduce chronic stress and anxiety in their lives or they may be at increased risk for developing depression and even dementia.

22 Jan 2016

New machine-learning technique could be used to uncover previously unknown features of organisms

A powerful new machine-learning technique can be applied to large datasets in the biological sciences to uncover previously unknown features of organisms and their genes, according to a team led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

22 Jan 2016

Oxeia accelerating development of neurometabolic treatments for concussions

Oxeia Biopharmaceuticals, Inc., a biotechnology company, is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.

21 Jan 2016

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Allergan plc announced today the publication of the positive results of the Phase III trials of VIBERZITM C IV (eluxadoline) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in the January 21 issue of The New England Journal of Medicine.

21 Jan 2016

Temple University Hospital makes strides in confronting prescription drug abuse

Prescription drug abuse has become a public health crisis in the U.S., and Temple University Hospital has made strides in confronting this critical situation.

21 Jan 2016

Patients undergoing surgery in hospitals with best nursing care have better outcomes

Patients are often unaware that choosing the right hospital is very important to having a good outcome. A novel study published today in the prominent surgery journal JAMA Surgery showed that patients undergoing surgery at Magnet hospitals recognized for nursing excellence, and good nurse staffing, have better outcomes at the same or lower costs as other hospitals.

21 Jan 2016

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

A study published in the Journal of Headache and Pain, carried out by Dr. Thomas Kinfe of the University of Bonn, found that twice daily stimulation of the vagus nerve with the hand-held gammaCore nVNS device reduced the number of headache days per month from 14.7 to 8.9 (p<0.001) and the number of monthly migraine attacks from 7.3 to 4.5 (p<0.001).

21 Jan 2016

Traditional acupuncture no better than fake acupuncture for treating menopause symptoms

A new study has revealed traditional Chinese acupuncture treatments are no better than fake acupuncture for treating menopause symptoms.

20 Jan 2016

Easy access to children's GPs reduces visits to emergency departments

Children whose GPs are easy to access are less likely to visit A&E than those whose GPs are less able to provide appointments. During weekdays, children's visits to A&E peak after school hours.

20 Jan 2016

Chronic News and Research

Opioid medication does not improve physical function in patients with neuropathic pain

Heat waves increase mortality risk in patients with lung disease

Chronic exposure to environmental toxin may up risk of neurodegenerative illness

Parathyroid hormone may mediate antihypertensive fracture risk

Positive bosutinib response for elderly blast phase CML patient

Cardiovascular considerations crucial for CML TKI patients

BCR–ABL transcript type linked to TKI response, outcomes

Levels of mitochondrial DNA in the blood may predict chronic kidney disease risk

Study finds possibility of targeting Orai3 as novel treatment for obesity-related inflammation

New interprofessional program aims to provide primary care and dental services to older adults

New study identifies DKK3 as a driver of kidney fibrosis

People suffering from chronic stress, anxiety may be at increased risk for depression and dementia

New machine-learning technique could be used to uncover previously unknown features of organisms

Oxeia accelerating development of neurometabolic treatments for concussions

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Temple University Hospital makes strides in confronting prescription drug abuse

Patients undergoing surgery in hospitals with best nursing care have better outcomes

Twice-daily stimulation of vagus nerve with gammaCore nVNS device reduces number of migraine attacks

Traditional acupuncture no better than fake acupuncture for treating menopause symptoms

Easy access to children's GPs reduces visits to emergency departments

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News